Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FAKRQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,770
Award facts
- Contract value 100% obligated
- $20,770.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,770.18 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with a firm fixed-price structure. This contract, awarded on January 29, 2026, with completion scheduled for January 30, 2026, represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. The work will be performed at the awardee's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's critical role in supplying specialized pharmaceuticals to military treatment facilities and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. As a major pharmaceutical distributor, Cencora, Inc./AmerisourceBergen maintains an extensive portfolio of federal contracts supplying prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. The firm's competitive positioning and established contract vehicles with the Defense Logistics Agency enable efficient fulfillment of essential pharmaceutical requirements for federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FAKRQ?
SPE2DR26FAKRQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FAKRQ worth?
The government has obligated $20,770 on SPE2DR26FAKRQ.
Is contract SPE2DR26FAKRQ an order under another contract?
Yes. SPE2DR26FAKRQ is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKRQ competed?
The extent of competition for SPE2DR26FAKRQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award